Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Eukaryotic Compartmentalizations

Eukaryotic Compartmentalizations

One of the distinguishing features of eukaryotic cells is that they contain membrane-bound organelles, such as the nucleus and mitochondria, that carry out specialized functions. Since biological membranes are only selectively permeable to solutes, they help create a compartment with controlled conditions inside an organelle. These microenvironments are tailored to the organelle's specific functions and help isolate them from the surrounding cytosol.
For example, lysosomes in the animal cells...

Eukaryotic Compartmentalization

Eukaryotic Compartmentalization

One of the distinguishing features of eukaryotic cells is that they contain membrane-bound organelles, such as the nucleus and mitochondria, that carry out specialized functions. Since biological membranes are only selectively permeable to solutes, they help create a compartment with controlled conditions inside an organelle. These microenvironments are tailored to the organelle's specific functions and help isolate them from the surrounding cytosol.
For example, lysosomes in the animal cells...

Eukaryotic Compartmentalization

Eukaryotic Compartmentalization

One of the distinguishing features of eukaryotic cells is that they contain membrane-bound organelles, such as the nucleus and mitochondria, that carry out specialized functions. Since biological membranes are only selectively permeable to solutes, they help create a compartment with controlled conditions inside an organelle. These microenvironments are tailored to the organelle's specific functions and help isolate them from the surrounding cytosol.
For example, lysosomes in the animal cells...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

Eukaryotic Evolution

Eukaryotic Evolution

The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...

Genomic DNA in Eukaryotes

Genomic DNA in Eukaryotes

Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.

Alternatives to laboratory animals : ATLA·2019

Same author

No time like the present - two hundred years of Parkinson's disease.

Alternatives to laboratory animals : ATLA·2017

Same author

Animal experimentation and alternatives: revealed preferences.

Alternatives to laboratory animals : ATLA·2017

Same author

Animal experimentation: the statistics speak for themselves.

Alternatives to laboratory animals : ATLA·2017

Same author

An approach to minimise dog use in regulatory toxicology: production of a best practice guide to study design.

Alternatives to laboratory animals : ATLA·2013

Same author

In vitro models of inhalation toxicity and disease. The report of a FRAME workshop.

Alternatives to laboratory animals : ATLA·2009

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Published on: April 8, 2017

Introduction to the EU REACH legislation.

Christina Grindon¹, Robert Combes

¹FRAME, Nottingham, UK. frame@frame.org.uk

Alternatives to Laboratory Animals : ATLA

|December 17, 2008

Summary

FRAME

Area of Science:

Toxicology and Chemical Safety
Regulatory Science
Animal Welfare Science

Background:

The European Union's Registration, Evaluation, and Authorisation of Chemicals (REACH) system was proposed in 2001.
FRAME has actively engaged with the REACH legislative process.
Concerns regarding scientific validity and animal welfare in chemical safety testing were raised.

Purpose of the Study:

To summarise FRAME's initiatives concerning the REACH system.
To highlight FRAME's contributions to addressing scientific and animal welfare issues within REACH.
To document the impact of FRAME's suggestions on the REACH legislation.

Main Methods:

Review of FRAME's position papers and communications regarding REACH.
Analysis of the evolution of REACH legislation in response to stakeholder input.

More Related Videos

Metabolic Labeling of the Nascent Transcriptome in Xenopus Early Embryogenesis

Metabolic Labeling of the Nascent Transcriptome in Xenopus Early Embryogenesis

Published on: March 27, 2026

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Published on: April 4, 2016

Related Experiment Videos

Last Updated: Jun 27, 2026

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Transcriptomic Analysis of C. elegans RNA Sequencing Data Through the Tuxedo Suite on the Galaxy Project

Published on: April 8, 2017

Metabolic Labeling of the Nascent Transcriptome in Xenopus Early Embryogenesis

Metabolic Labeling of the Nascent Transcriptome in Xenopus Early Embryogenesis

Published on: March 27, 2026

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Published on: April 4, 2016

Tracking of adopted suggestions and their integration into the final REACH framework.

Main Results:

FRAME's initiatives focused on improving the scientific basis and ethical considerations of chemical safety assessments under REACH.
Several suggestions proposed by FRAME appear to have been incorporated into the REACH legislation.
The process demonstrated a responsiveness of the European Council and Parliament to scientific and animal welfare concerns.

Conclusions:

FRAME's engagement has positively influenced the development of the REACH system.
The initiatives contributed to enhancing both the scientific robustness and animal welfare aspects of chemical regulation in the EU.
The success of these initiatives underscores the importance of proactive stakeholder involvement in regulatory development.